Based on the news about the stock in the past five trading days, please predict the rise or fall of the stock in the next trading day. If the stock is predicted to rise in the next trading day, please output [Rise], if the stock is predicted to fall in the next trading day, please output [Decrease].

Date:2020-10-27, Stock:LLY, The news for the past five days is as follows:
2020-10-20: NEWS1: ELI LILLY AND COMPANY ALERT: Bragar Eagel & Squire, P.C. is Investigating Eli Lilly and Company on Behalf of Eli Lilly Stockholders and Encourages Investors to Contact the Firm.NEWS2: Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know.NEWS3: Coronavirus Latest: Tuesday, October 20.NEWS4: The Law Offices of Frank R. Cruz Continues Its Investigation of Eli Lilly and Company (LLY) on Behalf of Investors.NEWS5: Eli Lilly (LLY) Earnings Expected to Grow: Should You Buy?.NEWS6: INVESTOR ALERT: Law Offices of Howard G. Smith Continues Investigation of Eli Lilly and Company (LLY) on Behalf of Investors.NEWS7: Eli Lilly Investor Alert: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses Exceeding $100,000 Investing In Eli Lilly and Company To Contact The Firm.
2020-10-21: NEWS1: Coronavirus Latest: Wednesday, October 21.NEWS2: ONGOING INVESTIGATION REMINDER: The Schall Law Firm Announces it is Investigating Claims Against Eli Lilly and Company and Encourages Investors with Losses of $100,000 to Contact the Firm.NEWS3: Fauci Tells Doctors Covid is Worse in the U.S. Because of a Failure to Avoid Crowds.NEWS4: Will Lilly (LLY) Witness Recovery in Sales in Q3 Earnings?.NEWS5: Lilly hires outside advisor for COVID drug plant problems.NEWS6: Lilly hires external adviser for COVID-19 drug plant problems.NEWS7: SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Eli Lilly and Company - LLY.
2020-10-22: NEWS1: Investor Alert: Kaplan Fox Investigates Eli Lilly For Potential Securities Fraud.NEWS2: Coronavirus Latest: Thursday, October 22.NEWS3: Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus.
2020-10-23: NEWS1: Remdesivir Gets FDA Approval. What It Means for Gilead Stock and Vaccine Makers..NEWS2: Remdesivir ‘is not a knock out punch’ but it does help patients ‘recover quicker’: doctor.NEWS3: Pharmaceutical companies ‘are doing a good job’ with efficacy and transparency: physician.NEWS4: Roche (RHHBY) Inks Deal to Develop Oral Coronavirus Treatment.NEWS5: Benzinga's Top Upgrades, Downgrades For October 23, 2020.NEWS6: New Jardiance® findings showed improved cardio-renal outcomes in adults with heart failure with reduced ejection fraction regardless of chronic kidney disease status.NEWS7: Healthcare to Post Solid Q3 Earnings Growth: ETFs in Focus.
2020-10-26: NEWS1: Eli Lilly antibody drug fails in a COVID-19 study; other studies go on.NEWS2: Were Hedge Funds Right About Eli Lilly and Company (LLY)?.

Answer: Decrease